Product How it works Pricing Blog FAQ About Contact
Xeris Biopharma

Xeris Biopharma (NASDAQ: XERS) revenue

Xeris Biopharma reported revenue of $291.8m for fiscal 2025, 43.7% more than in fiscal 2024 ($203.1m). Since fiscal 2020 its revenue has grown by 1,328.2%, an average growth of 70.2% a year.

Xeris Biopharma has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 6 fiscal years on record.

Revenue, in millions of US dollars20.4202049.62021110.22022163.92023203.12024291.82025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$291.8m+43.7%$24.9m8.5%
2024$203.1m+23.9%−$33.6m−16.6%
2023$163.9m+48.7%−$44.0m−26.8%
2022$110.2m+122.3%−$81.9m−74.3%
2021$49.6m+142.7%−$115.2m−232.2%
2020$20.4m—−$83.5m−408.8%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Xeris Biopharma revenue compared with its sector

By revenue for its latest fiscal year, Xeris Biopharma ranks 223rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Xeris Biopharma, 43.7%.

RankCompanyRevenueRevenue growth
221stIronwood Pharmaceuticals$296.2m−15.7%
222ndRigel Pharmaceuticals$294.3m64.1%
223rdXeris Biopharma$291.8m43.7%
224thAurinia Pharmaceuticals$283.1m20.4%
225thAdaptive Biotechnologies$277.0m54.8%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Xeris Biopharma

How much revenue did Xeris Biopharma make in fiscal 2025?
Xeris Biopharma reported revenue of $291.8m for fiscal 2025, compared with $203.1m in fiscal 2024.
How much has the revenue of Xeris Biopharma grown?
Between fiscal 2020 and fiscal 2025 it went from $20.4m to $291.8m: 1,328.2% more, an average growth of 70.2% a year.
What was the best year for revenue at Xeris Biopharma?
Of its last 6 fiscal years, fiscal 2025, with $291.8m.
Where does Xeris Biopharma rank in its sector by revenue?
It ranks 223rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Xeris Biopharma come from?
From the annual report (Form 10-K) that Xeris Biopharma files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Xeris Biopharma files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Xeris Biopharma: the Xeris Biopharma page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.